Luminar Technologies, Inc. (LAZR) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to loss of $0.24 per share a year ago. These ...
Marketscategory Illumina to divest cancer test maker Grail after antitrust battles December 18, 2023 Marketscategory Rocky history of Illumina's Grail deal December 18, 2023 Worldcategory US court ...
Time, Inc. engages in the publication of magazines. Its operations include websites, magazine subscriptions, and newsstand sales. Its product portfolio includes style & entertainment, lifestyle ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Illumina, Inc. (NASDAQ:ILMN) Q1 2024 Earnings Call Transcript May 2 ... we are now providing our customers with the full suite of NovoSeq X products. In Q1, we also made XLEAP-SBS chemistry available ...